CYSTI CARE
Food supplement declared in France, declaration No 2022-10-20
CYSTI CARE (HSN) is a food supplement declared in France. Status: retrait du marché annoncé pour le 12 June 2029. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- HSN
- Food business operator placing the product on the market
- HARRISON SPORT NUTRITION, S.L.
- Status
- Retrait du marché annoncé pour le 12 June 2029
- Form
- Capsule
- Daily dose
- 4 capsules
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Maladie rénale, Utilisation prolongée
- Objectives stated by the manufacturer (these are not authorised claims)
- Système urinaire
Declaration 237567, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 12 June 2029, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Arctostaphylos uva-ursi (L.) Spreng. | Feuille | Extrait sec hydroalcoolique | 750 mg |
| Vaccinium macrocarpon Aiton | Baie | Extrait sec hydroalcoolique | 350 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Mannose | not declared |
| L-leucine | not declared |
| Fructo-oligosaccharides | not declared |
Micro-organisms
| Strain | Per day |
|---|---|
| Lactobacillus Plantarum Lactobacillus Plantarum | 2,000,000,000 (unit not declared) |
| Lactobacillus Acidophilus Lactobacillus Acidophilus | 1,000,000,000 (unit not declared) |
| Lactobacillus Reuteri Lactobacillus Reuteri | 1,000,000,000 (unit not declared) |
| Streptococcus Thermophilus Streptococcus Thermophilus | 1,000,000,000 (unit not declared) |
| Lactobacillus Casei Lactobacillus Casei | 1,000,000,000 (unit not declared) |
| Lactobacillus Rhamnosus Lactobacillus Rhamnosus | 1,000,000,000 (unit not declared) |
| Bifidobacterium Bifidum Bifidobacterium Bifidum | 1,000,000,000 (unit not declared) |
| Bifidobacterium Breve Bifidobacterium Breve | 1,000,000,000 (unit not declared) |
| Bifidobacterium Lactis Bifidobacterium Lactis | 1,000,000,000 (unit not declared) |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acétate de rétinyle | Vitamine A | 3,000 µg d'équivalent rétinol | 800 µg |
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
Additives
E464
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux personnes souffrant d'insuffisance rénale, aux femmes allaitantes, aux femmes enceintes ou désireuses de l’être, aux femmes ménopausées, aux enfants et aux adolescents. L'utilisation doit être limitée dans le temps (pas plus d'une semaine).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- CYSTI CARE HSN, declared in 2026 : different composition: 7 ingredient(s) added, 7 missing
Brand : HSN